PL3886579T5 - Leczenie narządu ex vivo cząsteczkami peg-fosfolipidu - Google Patents
Leczenie narządu ex vivo cząsteczkami peg-fosfolipiduInfo
- Publication number
- PL3886579T5 PL3886579T5 PL19889740.7T PL19889740T PL3886579T5 PL 3886579 T5 PL3886579 T5 PL 3886579T5 PL 19889740 T PL19889740 T PL 19889740T PL 3886579 T5 PL3886579 T5 PL 3886579T5
- Authority
- PL
- Poland
- Prior art keywords
- peg
- phospholipid molecules
- vivo organ
- organ treatment
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1851492 | 2018-11-30 | ||
| PCT/SE2019/051215 WO2020112018A1 (en) | 2018-11-30 | 2019-11-29 | Ex vivo organ treatment with peg-phospholipid molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL3886579T3 PL3886579T3 (pl) | 2023-08-28 |
| PL3886579T5 true PL3886579T5 (pl) | 2026-02-09 |
Family
ID=70851858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19889740.7T PL3886579T5 (pl) | 2018-11-30 | 2019-11-29 | Leczenie narządu ex vivo cząsteczkami peg-fosfolipidu |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220022447A1 (pl) |
| EP (1) | EP3886579B2 (pl) |
| JP (1) | JP7465567B2 (pl) |
| KR (1) | KR102828292B1 (pl) |
| CN (1) | CN113056193B (pl) |
| AU (1) | AU2019390222B2 (pl) |
| CA (1) | CA3120057C (pl) |
| ES (1) | ES2949977T5 (pl) |
| IL (1) | IL283265B2 (pl) |
| MX (1) | MX2021005859A (pl) |
| PL (1) | PL3886579T5 (pl) |
| WO (1) | WO2020112018A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3886579B2 (en) | 2018-11-30 | 2025-12-24 | iCoat Medical AB | Ex vivo organ treatment with peg-phospholipid molecules |
| MX2022006021A (es) * | 2020-01-15 | 2022-09-07 | Icoat Medical Ab | Peg-lipido. |
| AU2022258815A1 (en) * | 2021-04-15 | 2023-10-19 | Abionyx Pharma Sa | Use of lipid binding protein-based complexes in organ preservation solutions |
| CN114225115B (zh) * | 2021-09-27 | 2023-03-17 | 南开大学 | 无损修饰的含有活细胞的血管替代物及制备方法 |
| MX2024010825A (es) * | 2022-03-07 | 2024-09-17 | Icoat Medical Ab | Nuevo uso de moleculas de peg-fosfolipido. |
| US20250366467A1 (en) * | 2022-06-15 | 2025-12-04 | Virginia Commonwealth University | Methods for fluid resuscitation of an organ donor |
| US11704507B1 (en) | 2022-10-31 | 2023-07-18 | Kudo, Inc. | Systems and methods for automatic speech translation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2301921A1 (en) | 1997-08-20 | 1999-02-25 | John Graham Goddard | Compositions containing polyethylene glycol and uses thereof |
| JP2006524260A (ja) * | 2003-04-23 | 2006-10-26 | ヒューマン バイオシステムズ | ドナー臓器の貯蔵用の改良された方法及び溶液 |
| EP1856973A4 (en) † | 2005-03-04 | 2011-10-12 | Nat Univ Corp Tokyo Med & Dent | SOLUTION FOR MAINTAINING AND IMPROVING ORGAN FUNCTION |
| AU2012231821B2 (en) † | 2011-03-23 | 2016-09-15 | Vivoline Medical Ab | Apparatus for maintaining a harvested organ viable and transportable |
| US9399027B2 (en) * | 2011-09-08 | 2016-07-26 | Virginia Commonwealth University | Organ protection solution and its method of use |
| US10433538B2 (en) * | 2012-10-12 | 2019-10-08 | University of Pittsburgh—of the Commonwealth System of Higher Education | Compositions and methods for organ preservation |
| CN103626993B (zh) * | 2013-11-05 | 2016-01-20 | 南京理工大学 | 聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物及其制备 |
| EP3886579B2 (en) | 2018-11-30 | 2025-12-24 | iCoat Medical AB | Ex vivo organ treatment with peg-phospholipid molecules |
-
2019
- 2019-11-29 EP EP19889740.7A patent/EP3886579B2/en active Active
- 2019-11-29 ES ES19889740T patent/ES2949977T5/es active Active
- 2019-11-29 CN CN201980076341.8A patent/CN113056193B/zh active Active
- 2019-11-29 JP JP2021529705A patent/JP7465567B2/ja active Active
- 2019-11-29 KR KR1020217015251A patent/KR102828292B1/ko active Active
- 2019-11-29 WO PCT/SE2019/051215 patent/WO2020112018A1/en not_active Ceased
- 2019-11-29 US US17/297,112 patent/US20220022447A1/en active Pending
- 2019-11-29 IL IL283265A patent/IL283265B2/en unknown
- 2019-11-29 PL PL19889740.7T patent/PL3886579T5/pl unknown
- 2019-11-29 CA CA3120057A patent/CA3120057C/en active Active
- 2019-11-29 MX MX2021005859A patent/MX2021005859A/es unknown
- 2019-11-29 AU AU2019390222A patent/AU2019390222B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2949977T5 (en) | 2026-03-25 |
| CA3120057A1 (en) | 2020-06-04 |
| IL283265B1 (en) | 2024-04-01 |
| JP2022511767A (ja) | 2022-02-01 |
| EP3886579B1 (en) | 2023-06-07 |
| US20220022447A1 (en) | 2022-01-27 |
| CN113056193A (zh) | 2021-06-29 |
| EP3886579C0 (en) | 2023-06-07 |
| CN113056193B (zh) | 2022-12-20 |
| JP7465567B2 (ja) | 2024-04-11 |
| PL3886579T3 (pl) | 2023-08-28 |
| EP3886579A4 (en) | 2022-09-07 |
| WO2020112018A1 (en) | 2020-06-04 |
| AU2019390222A1 (en) | 2021-05-27 |
| IL283265B2 (en) | 2024-08-01 |
| CA3120057C (en) | 2025-05-27 |
| EP3886579B2 (en) | 2025-12-24 |
| EP3886579A1 (en) | 2021-10-06 |
| AU2019390222B2 (en) | 2023-12-14 |
| KR20210097114A (ko) | 2021-08-06 |
| ES2949977T3 (es) | 2023-10-04 |
| IL283265A (en) | 2021-07-29 |
| BR112021009984A2 (pt) | 2021-08-17 |
| KR102828292B1 (ko) | 2025-07-03 |
| MX2021005859A (es) | 2021-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273550A (en) | Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the I148M variant of PNPLA3 | |
| EP3886579C0 (en) | Ex vivo organ treatment with peg-phospholipid molecules | |
| PL3631454T3 (pl) | Leczenie guzów lag-3 pozytywnych | |
| IL267795A (en) | Combined treatment for cancer | |
| PT3576740T (pt) | Tratamento de cancro | |
| IL268463A (en) | Cancer treatment | |
| GB201706451D0 (en) | Cancer treatment | |
| ZA202100482B (en) | Aromatic molecules for use in the treatment of pathological conditions | |
| IL274626A (en) | Cancer treatment | |
| IL279277A (en) | In vivo controlled combination therapy for treatment of cancer | |
| IL266993A (en) | Combined therapy for cancer treatment | |
| ZA202100421B (en) | Aromatic molecules for use in the treatment of pathological conditions | |
| GB201707864D0 (en) | Platinum-reistant cancer treatment | |
| EP3706752A4 (en) | COMBINATORY THERAPY FOR ANTI-CANCER TREATMENT | |
| IL288905A (en) | diagnosis and treatment | |
| ZA202001435B (en) | Abx196 for use in the treatment of bladder cancer | |
| GB201906975D0 (en) | Treatment of ards | |
| GB201908076D0 (en) | Skin treatment composition | |
| IL253642A0 (en) | Combined treatment for cancer | |
| HK40032616A (en) | Diagnostic and treatment kit | |
| GB201907149D0 (en) | Cancer treatment | |
| GB201801195D0 (en) | Skin repair treatment | |
| GB201811431D0 (en) | Cancer treatment | |
| GB201902580D0 (en) | Treatment | |
| GB201804816D0 (en) | Cancer treatment |